LSM-775: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject |
Fixed spacing between stub template and category templates |
||
(34 intermediate revisions by 24 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Unreferenced stub|auto=yes|date=December 2009}} |
|||
{{Drugbox |
{{Drugbox |
||
| Watchedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = 447574259 |
||
| IUPAC_name = (8β)- |
| IUPAC_name = (8β)-6-Methyl-8-(morpholin-4-ylcarbonyl)-9,10-didehydroergoline |
||
| image = LSM-775.svg |
| image = LSM-775.svg |
||
| width = 200 |
| width = 200 |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| legal_AU = |
| legal_AU = |
||
| legal_CA = |
| legal_CA = |
||
| |
| legal_DE = NpSG |
||
| |
| legal_UK = PSA |
||
| legal_US = |
|||
⚫ | |||
| legal_status = Illegal in France<ref>{{cite web|date=20 May 2021|title=Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants | trans-title = Order of May 20, 2021 amending the order of February 22, 1990 setting the list of substances classified as narcotics |url=https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000043523554|website=www.legifrance.gouv.fr|lang=fr}}</ref> |
|||
⚫ | |||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 19: | Line 22: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 4314-63-0 |
| CAS_number = 4314-63-0 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 168Y0PXM7S |
|||
| PubChem = 199507 |
| PubChem = 199507 |
||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
Line 25: | Line 31: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=20 | H=23 | N=3 | O=2 |
| C=20 | H=23 | N=3 | O=2 |
||
⚫ | |||
| molecular_weight = 337.43 g/mol |
|||
⚫ | |||
| InChI = 1/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3/t14-,18-/m1/s1 |
|||
| InChIKey = OTQWCDNEJVKXKG-RDTXWAMCBG |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3/t14-,18-/m1/s1 |
| StdInChI = 1S/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3/t14-,18-/m1/s1 |
||
Line 37: | Line 40: | ||
}} |
}} |
||
'''''N''-Morpholinyllysergamide''' (LSM-775) is a derivative of [[ergine]]. It is reported to have some [[LSD]]-like effects at doses ranging from 75 to 700 micrograms |
'''''N''-Morpholinyllysergamide''' ('''LSM-775''') is a derivative of [[ergine]].<ref>{{cite journal | vauthors = Gogerty JH, Dille JM | title = Pharmacology of d-lysergic acid morpholide (LSM) | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 120 | issue = 3 | pages = 340–8 | date = July 1957 | pmid = 13476356 | url = http://jpet.aspetjournals.org/content/120/3/340.abstract }}</ref> It is less potent than LSD but is reported to have some [[Lysergic acid diethylamide|LSD]]-like effects at doses ranging from 75 to 700 micrograms and a shorter duration. There are fewer signs of [[cardiovascular]] [[stimulation]] and [[Peripheral nervous system|peripheral]] [[Antitarget|toxicity]] with LSM-775 compared to LSD.<ref name="TiHKAL">{{cite web |url = https://www.erowid.org/library/books_online/tihkal/tihkal26.shtml |title = TiHKAL #26, LSD-25 |publisher = Erowid| vauthors = Shulgin A, Shulgin A }}</ref>{{dubious|date=March 2019}} |
||
== See also == |
|||
{{Hallucinogenic lysergamides}} |
|||
* [[1cP-LSD]] |
|||
* [[1B-LSD]] |
|||
* [[1P-ETH-LAD]] |
|||
* [[1P-LSD]] |
|||
* [[1V-LSD]] |
|||
* [[ALD-52]] |
|||
* [[AL-LAD]] |
|||
* [[ETH-LAD]] |
|||
* [[Lysergic acid 2,4-dimethylazetidide]] (LSZ) |
|||
* [[Lysergic acid diethylamide]] (LSD) |
|||
* [[O-Acetylpsilocin]] (4-AcO-DMT) |
|||
* [[PRO-LAD]] |
|||
== References == |
|||
⚫ | |||
{{reflist}} |
|||
⚫ | |||
{{Hallucinogens}} |
|||
{{Serotonergics}} |
|||
{{Ergolines}} |
|||
[[Category:Lysergamides]] |
[[Category:Lysergamides]] |
||
[[Category: |
[[Category:4-Morpholinyl compounds]] |
||
[[Category:Serotonin receptor agonists]] |
|||
[[Category:Designer drugs]] |
|||